MBA’s Broeksmit on Trump Orders, AI and Mortgage Affordability
At ICE X26, MBA President Bob Broeksmit outlined how Trump orders, AI-driven underwriting, and tight housing supply a...
Which Travel Cards Have No Annual Fee
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articles
Nvidia's $2.2 Billion Investment Fuels Rapid AI Growth
When a tech giant like Nvidia makes a bold $2.2 billion investment in a fast-growing AI company, it signals more than...
Intuitive Machines Wins NASA: Investing Outlook Ahead
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
GenZ's High Yield Can't Survive Shift From Casinos to Apps
VanEck’s Gaming ETF has retooled into a Digital Native Economy ETF, raising doubts about whether its income story can...
Your Part D Drug Plan Costs $0, Medicare Still Bills You Up to $91
A zero-premium Part D plan can still trigger the IRMAA surcharge, adding as much as $91 a month for certain retirees....
Record Heat Dome Drives Grid to Peak Demand: 4 Stocks
A historic heat dome pushed the PJM grid toward an all-time peak. This investing backdrop highlights four power stock...
Tired Watching Your Stocks? Try This Safer Investment Path
Feeling weary from stock swings? This practical guide offers a safer, simpler investment path using broad-market fund...
Oracle's Backlog: Potential Windfall or Time Bomb?
Backlogs can unlock revenue visibility, but they can also mask quality issues. This article explains how to assess or...
Just Lost Your Spouse? Make This Social Security Move ASAP.
Losing a partner upends more than your personal life—it can reshape your income too. This guide walks you through the...
61-Year-Old with $1.6 Million Could Walk Away by 2027
A concrete retirement deadline hinges on two numbers: the day-one portfolio balance and MAGI staying below ACA subsid...
CEO Sells Shares Biotech Stock: Understanding Insider Moves
When a biotech company’s leader sells shares, it can raise questions for investors. This guide breaks down how to int...
AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status